UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 10, 2010
GENOMIC HEALTH, INC.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
|
| Delaware
|
|
000-51541
|
|
77-0552594 |
(State or Other
Jurisdiction of
Incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.) |
| |
|
|
|
| 301 Penobscot Drive |
|
|
| Redwood City, CA
|
|
94063 |
| (Address of principal executive offices)
|
|
(Zip Code) |
(650) 556-9300
(Registrant’s telephone number,
including area code)
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligations of the registrant under any of the following provisions (see General Instruction
A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240-13e-4(c))
Item 5.07 Submission of Matters to a Vote of Security Holders.
The following actions were taken at the Annual Meeting of Stockholders of Genomic Health,
Inc., held on June 10, 2010:
1. The following Directors were elected to serve until the 2011 Annual
Meeting or until their successors are duly elected and qualified:
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Broker |
|
| |
|
For |
|
|
Withheld |
|
|
Non-Votes |
|
Randal W. Scott, Ph.D. |
|
|
15,774,354 |
|
|
|
28,137 |
|
|
|
3,011,248 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Kimberly J. Popovits |
|
|
15,778,718 |
|
|
|
23,773 |
|
|
|
3,011,248 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Julian C. Baker |
|
|
15,230,393 |
|
|
|
572,098 |
|
|
|
3,011,248 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brook H. Byers |
|
|
15,780,948 |
|
|
|
21,543 |
|
|
|
3,011,248 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fred E. Cohen, M.D., D.Phil. |
|
|
15,779,751 |
|
|
|
22,740 |
|
|
|
3,011,248 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Samuel D. Colella |
|
|
15,780,226 |
|
|
|
22,265 |
|
|
|
3,011,248 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ginger L. Graham |
|
|
15,654,598 |
|
|
|
147,893 |
|
|
|
3,011,248 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Randall S. Livingston |
|
|
15,779,551 |
|
|
|
22,940 |
|
|
|
3,011,248 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Woodrow A. Myers, Jr., M.D. |
|
|
15,780,751 |
|
|
|
21,740 |
|
|
|
3,011,248 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2. The ratification of the appointment of Ernst & Young LLP as the Company’s
independent registered public accounting firm for the 2010 fiscal year was approved.
| |
|
|
|
|
| For |
|
Against |
|
Abstain |
18,765,011
|
|
40,454
|
|
8,274 |